ArticleTargeted oncology2026

Baseline Disease Characteristics and Platinum Sensitivity as Predictors of Outcomes in Sequential Therapy with Platinum-Based Chemotherapy, Avelumab Maintenance, and Enfortumab Vedotin in Advanced Urothelial Carcinoma (ARON-2EV Study).

Mimma Rizzo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.